TDP1 and TOP1 levels are key determinants of irinotecan response in colorectal cancer cells and TDP1 depletion has been shown to sensitise the RKO cell line to irinotecan by increasing the number of cytotoxic DSBs (37,45). The gene discussed is TDP1; the disease is colorectal cancer.